Substituted phenyl oxazolidin-2-one compound
PK139983AUndetermined Publication Date: 2009-02-24MERCK & CO INC
0 Cites 0 Cited by
Patent Information
- Application Number
- PK200500595
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Publication Date
- 2009-02-24
Abstract
Compound having the structures of Formula I, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis: In the compound of Formula I, B or R2 is a phenyl group which has an ortho aryl, heterocyclic, benzoheterocyclic or benzocycloalky substituent, and one other position on the 5-membered ring has an aromatic, heterocydic, cycloalkyl, benzoheterocyclic or benzocycloalky substituent connected directly to the ring or attached to the ring through a -CH2-.
Need to check novelty before this filing date? Find Prior Art
